Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
NEW YORK, N.Y., March 12, 2024 (GLOBE NEWSWIRE) -- The Women in the Digital Economy Fund (WiDEF), a five-year $60.5 million investment to accelerate progress on closing the global gender digital...
-
BALTIMORE, March 12, 2024 (GLOBE NEWSWIRE) -- Royal Farms, a beloved East Coast convenience store and fried chicken destination, is thrilled to announce its upcoming expansion into Bedford,...
-
Shreveport, Louisiana, March 12, 2024 (GLOBE NEWSWIRE) -- In the heart of the film industry for over two decades, Lloyd Lyles, a seasoned producer at Sultan of Suave, traces his love for film back...
-
Vancouver, March 12, 2024 (GLOBE NEWSWIRE) -- Unceded traditional territories of the xwməθkwəy̓əm (Musqueam), Sḵwx̱wú7mesh (Squamish), and səlilwətaɬ (Tsleil-Waututh) Nations, Vancouver BC (March...
-
미국 보스턴, March 13, 2024 (GLOBE NEWSWIRE) -- 바이오텍과의 파트너십을 통해 임상시험 모든 단계에서 혁신적이고 새로운 치료제 개발을 가속화하는데 주력하는 글로벌 풀서비스 CRO인 노보텍(Novotech)이 듀센근이영양증(Duchenne Muscular Dystrophy, DMD) 임상시험 환경에 관한 업계 최신 보고서를...
-
波士頓, March 13, 2024 (GLOBE NEWSWIRE) -- Novotech提供全球全方位服務，與生物技術公司合作加速各階段進階和新穎療法開發的臨床合同研究組織 (CRO)，今天發布行業領先的杜氏肌營養不良症臨床試驗前景報告。 報告包括新興基因療法、資金形式和一份 SWOT 分析，旨在為戰略性藥物開發決策提供資訊，並最終提高 DMD...
-
波士顿, March 13, 2024 (GLOBE NEWSWIRE) -- Novotech提供全球全方位服务，与生物技术公司合作加速各阶段进阶和新颖疗法开发的临床合同研究组织 (CRO)，今天发布行业领先的杜氏肌营养不良症临床试验前景报告。 报告包括新兴基因疗法、资金形式和一份 SWOT 分析，旨在为战略性药物开发决策提供信息，并最终提高 DMD...
-
EXTON, PA, March 12, 2024 (GLOBE NEWSWIRE) -- For neurologists tasked with delivering the distressing diagnosis of Amyotrophic Lateral Sclerosis (ALS) or Alzheimer’s Disease (AD), the upcoming...
-
NEW YORK, March 12, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Envoy...
-
Information réglementée Paris, 12 mars 2024 DECLARATION N° 2024/01 DES TRANSACTIONS SUR ACTIONS PROPRES Période du : 5 mars au 8 mars 2024 Emetteur : Pluxee N.V. Catégorie de titres : Actions...